Lombardo Camilla, Vittorini Pierpaolo, Fabiani Leila, Aleandri Anna Rita, Ciogli Francesco, Fiorenza Marta, Scatigna Maria, De Luca Assunta
Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
Unit of Diabetology, San Camillo de Lellis Hospital, 02100 Rieti, Italy.
Healthcare (Basel). 2025 Feb 21;13(5):475. doi: 10.3390/healthcare13050475.
The Diabetes Self-Management Questionnaire (DSMQ) provides a multidimensional measure of diabetes self-management behaviors essential for glycemic control. However, the DSMQ has never been validated in Italy despite the increasing prevalence of diabetes. This study aims to validate the Italian version of the DSMQ (I-DSMQ), with an additional focus on patients with type 2 diabetes. Two samples of patients attending the diabetology clinic at the ASL of Rieti were selected. The first sample included 70 patients diagnosed with either Type 1 Diabetes Mellitus (T1DM) or Type 2 Diabetes Mellitus (T2DM), while the second sample consisted of 99 individuals diagnosed with T2DM. Both groups completed the same questionnaire, the Italian version (I-DSMQ) of the original 16-item DSMQ, two times. The results show that the Italian version maintains its reliability and consistency as an instrument applied to the Italian context in the self-management evaluation of patients with T1DM and T2DM. However, the Italian adaptation shows less satisfactory results considering only a subgroup of patients with T2DM. The I-DSMQ is a reliable and valid tool among Italian patients with T1DM and T2DM. Further insights are needed for the health usage domain if only T2DM patients are considered.
糖尿病自我管理问卷（DSMQ）提供了对血糖控制至关重要的糖尿病自我管理行为的多维度测量。然而，尽管糖尿病患病率不断上升，但DSMQ在意大利从未得到验证。本研究旨在验证意大利版的DSMQ（I-DSMQ），并特别关注2型糖尿病患者。选取了在列蒂地方卫生机构（ASL）糖尿病门诊就诊的两组患者。第一个样本包括70名被诊断为1型糖尿病（T1DM）或2型糖尿病（T2DM）的患者，而第二个样本由99名被诊断为T2DM的个体组成。两组都两次完成了相同的问卷，即原始16项DSMQ的意大利版（I-DSMQ）。结果表明，意大利版在应用于意大利背景下的T1DM和T2DM患者自我管理评估时，保持了其可靠性和一致性。然而，仅考虑T2DM患者的一个亚组时，意大利语改编版的结果不太令人满意。I-DSMQ在意大利的T1DM和T2DM患者中是一个可靠且有效的工具。如果仅考虑T2DM患者，在健康使用领域还需要进一步的见解。
